Log in

upcoming Events & webinars





webinars

    • 03 Mar 2017
    • 17 Sep 2018
    • at your convenience
    Register

    Genetic Factors in Traumatic Brain Injury Outcomes


    Presented by
    Katie Edwards, RN

    Description
    This webinar will provide a State of the Science overview on the topic of genetic variation and response to traumatic brain injury. The evidence identifies several genes with gene products in multiple pathways that are active after traumatic brain injury and amenable to therapeutic development. This presentation will highlight some of the genetic and biologic factors that result in differences in outcomes after traumatic brain injury.

    Who Should Attend?
    Nurse clinicians, nurse scientists and nurse educators who have an interest in genetic contributions to response to injury and brain injury.

    Objectives

    1. The learner will be able to discuss the significance of traumatic brain injury to the US and world population.
    2. The learner will recognize genetic factors associated with mild, moderate, severe, and penetrating TBI.
    3. The learner will explain potential clinical application and future research needs related to genetic influence on outcomes from TBI.

    The cost is $15.00 for ISONG Members / $25.00 for Non-members.

    Presenter
    Katie received her Bachelor of Science in Biology in 2007, and a Bachelor of 
    Science in Nursing from the University of South Carolina Upstate in 2010. Her nursing experience includes neuro/trauma ICU at a level one trauma hospital as well as neurorehabilitation. She is committed to improving the quality of life for patients recovering from traumatic brain injury. Katie is pursuing a PhD in Healthcare Genetics from Clemson University in South Carolina where she is focusing on the study of genetic variants important to traumatic brain injury recovery.

    This learning activity has been developed in collaboration with the University of Pittsburgh School of Nursing. Participants successfully completing this activity will be awarded one (1) continuing nursing education contact hour.

    The University of Pittsburgh School of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation

    • 03 Mar 2017
    • 19 Mar 2019
    • at your convenience
    Register

    Family History in Clinical Practice

     
    Presented by
    Suzanne Nichols
    MSN, BSN, RNC-BC, WHNP-BC
     
    Presented by
    Suzanne M. Mahon
    RN, DNSc AOCN, APNG

    Description
    This webinar would be helpful to nurses who wish to better understand how to construct an accurate family pedigree, pedigree analysis, and risk assessment principles. Concepts will be explored using clinical case examples.

    Target Audience
    Nurses in any clinical setting who want to advance their knowledge in obtaining a family history and pedigree, along with risk identification and appropriate genetic referral.

    Objectives

    1. Construct an accurate three generation pedigree.
    2. Describe at least two ways in which the pedigree can be utilized to better categorize risk for developing disease.
    3. Describe how pedigree analysis guides referrals for genetic assessment.

    Presented by: Suzanne M. Mahon, RN, DNSc AOCN, APNG
    Sue Nicholas, MSN, BSN, RNC-BC, WHNP-BC

    Presenters
    Dr. Suzanne Mahon is a Professor in the Division of Hematology/Oncology and a Professor in Adult Nursing in the School of Nursing at Saint Louis  University in St. Louis, Missouri. She instituted and has run the Hereditary Cancer Program there since 1999 where she has provided genetic counseling and educational services to over 4000 families. She has over 100 publications in the area of cancer prevention and cancer genetics in peer reviewed journals. She is the recipient of the 2011 ISONG Founders Award for Education to Professionals, Patients, and the Public. Dr. Mahon is also the recipient of the Saint Louis University 2012 School of Nursing Alumni Award which recognized an outstanding alumnus of the School of Nursing who exemplifies, in daily life, the mission of Saint Louis University and has achieved outstanding success in their professional life and in their intellectual pursuits.

    Ms Nicholas has spent 35 years caring for women across the care continuum with primary focus within the high risk obstetrical arena. She is passionate about the care of childbearing families as she believes they are
    our future. Her position at Akron Children's Hospital has afforded her the opportunity to coordinate the care of high risk families and expand her genetic/genomic expertise within the Fetal Care Center. In 2013, she was part of a dyad selected to participate in the MINC project (Methods of Incorporating Nursing Competencies) which expanded her knowledge of genetics and genomics. She has since become the nursing ambassador within her organization, educating nurses on the importance of family history, risk identification and utilization of our genetic services to improve the health of the patients we serve.

    Continuing nursing education credits 
    This learning activity has been developed in collaboration with the University of Pittsburgh School of Nursing.

    Participants successfully completing this activity will be awarded one (1) continuing nursing education contact hour.

    The University of Pittsburgh School of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.



    • 03 Mar 2017
    • 09 Apr 2019
    • at your convenience
    Register

    Pharmacogenetics and Your Clinical Practice


    Presented by
    Dennis J. Cheek
    RN, PhD, FAHA

    Description
    Genomics is a central science for all advanced practice nurses due to the fact that many diseases and conditions have a genetic or genomic component. In the imminent future, all health care will increasingly include genetic and genomic information including pathways of prevention, screening, diagnostics, pharmacology, selection of treatment, and monitoring of treatment effectiveness. This webinar will examine the advances in pharmacogenomics, which is the study of genetic/genomic variation and how these variation influence drug therapy.

    Target Audience
    Personalized medicine has arrived and this webinar is designed to provide the clinical nurse with the latest information on pharmacogenomics in their clinical practice. The webinar will also provide the advanced practice additional information on additional pharmacogenomics information for prescribing and monitoring of drug therapy.

    Objectives

    1. Explain the difference between genetics and genomics.
    2. Discuss the clinical importance of pharmacogenomics in the clinical setting.
    3. Discuss the role of the healthcare provider with regard to pharmacogenomics data and patient management. 

    Presenter
    Dennis J. Cheek, RN, PhD, FAHA is currently the Abell-Hanger Professor in Gerontological Nursing at Texas Christian University - Harris College of Nursing and Health Sciences with a joint appointment in the School of Nurse Anesthesia.

    He received his Bachelor of Science in Nursing from California State University, Fresno and his Masters of Science in Nursing from the University of California, San Francisco with a focus in Critical Care Nursing and Education. 

    He received his Doctor of Philosophy in Cellular & Molecular Pharmacology and Physiology from the University of Nevada, Reno and was awarded a Nevada AHA Affiliate Post - Doctoral Fellowship to continue his research. His teaching responsibilities include undergraduate pharmacology, graduate pathophysiology and pharmacology, nurse anesthesia pharmacology and cardiovascular physiology as well as one the core courses' in the Doctoral of Nursing Practice program at TCU. 

    Along with his teaching responsibilities, he is continuing his program of research in the newly renovated Nursing Research Laboratory studying the effects of age on endothelial cells. Dennis has been a member of the Council on Cardiovascular Nursing since 2000 and was inducted as a Fellow of the American Heart Association (FAHA). He has published in numerous journals including American Journal of Critical Care, American Association of Critical Care Nurses Clinical Issues, American Association of Nurse Anesthetist , American Journal of Physiology: Heart and Circulatory, Biological Research in Nursing, Circulation Research, Critical Care Nurse, Heart & Lung, Journal of Emergency Nursing, Journal of Nursing Scholarship, Proceedings of the National Academy of Sciences in the United States and The Journal of Cardiovascular Nursing.

    Continuing Educational Credits 
    This learning activity has been developed in collaboration with the University of Pittsburgh School of Nursing.

    Participants successfully completing this activity will be awarded one (1) continuing nursing education contact hour.

    The University of Pittsburgh School of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation



    • 03 Mar 2017
    • 10 May 2020
    • at your convenience
    Register
    Tailoring Nursing Assessment and Interventions to Provide Individualized Health Care


    Presented by
    Elizabeth L. Pestka
    PMHCNS-BC, APNG

    Description
    This presentation will focus on individualized health care including five overall aspects utilized by the Mayo Clinic Center for Individualized Medicine including pharmacogenomics, epigenetics, microbiome, clinomics, and biomarker development. Nurses in all clinical areas need to tailor care by including genetic and genomic information in their assessments and interventions and numerous examples of how this is currently being done will be part of the session. Finally, one successful interdisciplinary quality improvement project, initiated and led by nurses, will demonstrate how the use of family history information related to substance abuse can improve care for patients with chronic pain. Clinical implications include preventive interventions for more individuals, potential considerable health care cost savings, and a greater appreciation of the value of family history information by both providers and patients. This project has potential to be generalized for use with other health conditions.

    Who Should Attend?
    This presentation is for all professionals who want to learn more about integrating genomic assessments and interventions into nursing clinical practice. Nurses working in academic positions will be able to include the real examples in classroom discussions and nurses involved in clinical practice will be able to identify ways that genomic information is applicable in providing care to their patients.

    Presented by: 
    Elizabeth L. Pestka, PMHCNS-BC, APNG

    Ms. Elizabeth Pestka is a retired Clinical Nurse Specialist in the Pain Rehabilitation Center, Department of Psychiatry, and an Assistant Professor of Nursing at Mayo Clinic in Rochester, MN, USA. She received her BSN from Winona State University, Winona, MN, and her Master’s degree in nursing from the University of Minnesota, Minneapolis. She worked with an interdisciplinary team focused on helping persons with chronic pain learn management strategies to improve their level of functioning and quality of life. At this time the team is systematically using family history information, and other relevant genetic findings, to individualize patient care.

    Ms. Pestka was selected as a Genomics Co-Leader for the Department of Nursing at Mayo Clinic in 2001 and gained credentialing as an Advanced Practice Nurse in Genetics in 2005.  She has led a multifaceted genomics program which was selected by the American Nurses Credentialing Center for the prestigious Magnet Prize in 2005. She has served as Education Committee co- chair and secretary of the International Society of Nurses in Genetics, been a member of the national Genetics Nursing Credentialing Center Portfolio Score Team and was invited to serve on the Advisory Group for the National Council of State Boards of Nursing funded project focusing on a method for introducing a new competency into nursing practice. Her research has focused on the inclusion of genomics activities in non-genetic clinical nursing practice areas.

    Continuing Nursing Education Credits 
    This learning activity has been developed in collaboration with the University of Pittsburgh School of Nursing. Participants successfully completing this activity will be awarded one (1) continuing nursing education contact hour.

    The University of Pittsburgh School of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    • 03 Mar 2017
    • 01 Jun 2020
    • at your convenience
    Register
    Noninvasive Prenatal Screening Test: A New Screening Option for High Risk Pregnant Women


    Presented by
    Tina Mladenka
    DNP, APRN, CNP, WHNP-BC


    Presented by
    Christina Murphey
    PhD, RNC-OB

    Description
    Noninvasive prenatal screening test (NIPS) is a new option in prenatal testing that screens for trisomy 21 and other fetal chromosomal abnormalities. It analyzes cell-free fetal DNA from a sample of maternal blood. This webinar will provide information about noninvasive prenatal screening, including a description of the test, accuracy of the test, its advantages and limitations, indications for the test, pre- and post-test counseling, how it is different than current prenatal screening tests, ethical and legal implications of the test, and current professional recommendations for the test.

    Who Should Attend?
    Nurses, nurse practitioners, and other interdisciplinary health care providers who have minimal experience or educational preparation in genetics and are involved in prenatal care and/or want to know more information about noninvasive prenatal screening test for professional and personal reasons.

    Objectives

    1. Explain 3 key concepts regarding the noninvasive prenatal screening test (NIPS)
    2. Describe how NIPS test is different than current prenatal screening tests.
    3. Identify clients to whom NIPS test should be offered.
    4. Explain current professional recommendations for NIPS test.
    5. Describe basic ethical and legal aspects of NIPS

    Presented by: 
    Tina Mladenka, DNP, APRN, CNP, WHNP- BC
    Christina Murphey, PhD, RNC-OB

    Tina Mladenka is a Women's Health Nurse Practitioner who currently provides reproductive health services at Southeastern Idaho Public Health in Pocatello, ID. She is a NIH/NINR Fellow of the Summer Genetics Institute 2007 and is currently serving as Co-Chair for the ISONG Perinatal Nursing SIG. Dr. Mladenka has worked in a variety of practice, academic, and teaching roles in the areas of perinatal, reproductive, and women's health and health care genomics.

    Christina Murphey is an Assistant Professor and Director of the Graduate Maternity Program at The University of Texas at Austin, School of Nursing. She is a NIH/ NINR Fellow of the Summer Genetics Institute and has is currently serving as Co-Chair for the ISONG Perinatal Nursing SIG. Dr. Murphey has worked in a variety of research, academic, and teaching roles in the areas of health care genomics and perinatal health promotion.

    Cost
    $25.00 for ISONG Members 
    $50.00 for Non-members

    This learning activity has been developed in collaboration with the University of Pittsburgh School of Nursing.Participants successfully completing this activity will be awarded one (1) continuing nursing education contact hour.The University of Pittsburgh School of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    • 19 Apr 2017
    • 12:00 PM
    • 01 Apr 2020
    • 1:00 PM
    • Webinar
    Register

    Genetics and Implications of Metabolic Newborn Screening for Nurses


    Presented by

    Sarah Viall
    MSN, PPCNP-BC
    Description
    This session will briefly address the history of newborn screening, including the philosophy and technology behind the expanded newborn screen and the general logistics of its implementation nationally. The focus of the presentation will be a discussion of actions to be taken following abnormal results using lecture and case-study format with particular emphasis on the metabolic disorders more rarely diagnosed and discussed (i.e. fatty acid oxidation, organic acidurias, enzyme deficiencies). This webinar will include the basic pathophysiology of metabolic and genetic disorders, signs and symptoms to monitor prior to newborn screen results, indications indicative of false versus true positives, and resources available to assist in making clinical decisions and informing families of results.

    Who Should Attend?
    Any nurse working in Genetics or Primary Care, particularly those working in the care of newborns or infants.

    Objectives
    By the end of the webinar the attendees will be able to:

    1. Identify at least one source of information pertinent to the newborn screening program of the state or territory in which you practice.
    2. Differentiate between the distinct newborn screening disorder categories.
    3. Identify publicly available resources to assist in the nursing practice of triage and response to abnormal newborn screens.

    Presenter
    Sarah Viall, MSN, PPCNP-BC
    Newborn Screening and Telegenetics Program  Director
    Division of Genetics and Metabolism
    Children's National Health System
    Washington, DC USA

    Sarah Viall graduated from the Yale School of Nursing Pediatric Nurse Practitioner Program in 2012. Since that time she has worked as the Newborn Screening Follow-up Director of the Rare Disease Institute at Children's National Health System in Washington, DC. There, she specializes in the follow-up of newborns and children with metabolic disorders detected by newborn screening.

    Cost
    $25.00 for ISONG Members
    $50.00 for Non-Members
    $15 for Students 

    Contact Hours
    ISONG is collaborating with the University of Pittsburgh School of Nursing to provide this learning activity.  Participants completing this activity will receive a maximum of one hour of continuing nursing education contact hours. The University of Pittsburgh School of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

    • 17 May 2017
    • 4:00 PM
    • 15 May 2020
    • 5:00 PM
    • Webinar
    Register
    Women at Increased Risk for Breast Cancer Based on Family History: Calculating Lifetime Risk and Ordering Screening MRI Based on Current U.S. Guidelines

    Presented by
    Deborah O. Himes
    PhD, APRN-BC, ANP

     
    Presented by
    Amanda Gammon
    MS, CGC

    Description
    Several organizations recommend healthcare providers offer annual breast MRI to women with lifetime risk for breast cancer above 20%.  In this webinar, Deborah O. Himes and Amanda Gammon will review U.S. breast cancer screening guidelines and risk assessment models. The presenters will provide step-by-step instructions for calculating lifetime risk using the Tyrer-Cuzic model. Additionally, they will present a clinical decision making model to help assess which should  be referred for additional risk assessment and/or referral for genetic counseling.

    Who Should Attend?
    This presentation is intended for primary healthcare providers including nurses, nurse practitioners, physician assistants, and physicians who care for women who may be at increased risk for breast cancer.

    Objectives
    1. During this presentation attendees will learn to calculate lifetime risk for breast cancer using the Tyrer-Cuzick model.
    2. After this presentation, attendees will be able to explain differences in risk for breast cancer among women in differing risk categories (population, familial, hereditary) and screening guidelines based on risk category (mammography and breast MRI).
    3. After this presentation attendee will be able to describe three different models used for calculating lifetime risk for breast cancer.
    4.  Following this presentation attendees will understand how to select patients for in-depth risk assessment and/or referral for genetic counseling related to breast cancer risk. 

    Presenters
    Deborah O. Himes, PhD, APRN-BC, ANP 
    Asssitant Proffessor
    Brigham Young University
    College of Nursing
    Provo, Utah USA

    Amanda Gammon, MS, CGC
    Assistant Director, Genetic Counseling Graduate Program
    Licensed Genetic Counselor
    Family Cancer Assessment Clinic
    Provo, Utah USA

    Cost
    $15.00 for ISONG Members and Students
    $25.00 for Non-Members

    Contact Hours
    ISONG and the University of Pittsburgh School of Nursing are collaborating to provide this learning activity. Nurse participants completing the activity and the evaluation tool will receive one (1) continuing nursing education contact hour.  The University of Pittsburgh School of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

    • 08 Nov 2017
    • 12 Oct 2018
    • Book
    • 8
    Register

    "Mastering Pharmacogenomics, A Nurse's Handbook for Success" 

    A portion of the proceeds benefits ISONG - Thank you to STTI! 

    Congratulations to our ISONG members: Dennis Cheek and Dale Halsey Lea (Past-President), for their work on, "Mastering Pharmacogenomics, A Nurse's Handbook for Success."   

    Mastering Pharmacogenomics provides nursing professionals with a foundational knowledge of human genetics and genomics that can optimize drug therapy and patient care delivery.
    Coverage includes:

    ·        Essential pharmacogenomics competencies for registered nurses

    ·        Genomics technologies and resources

    ·        Critical properties of drug response and disposition

    ·        Application of pharmacogenomics to obstetrics, pediatrics, geriatrics, and oncology

    ·        Ethics and patient care

    ·        Future developments in technology and delivery 

    There were chapter contributions for this book from other ISONG members including: Ellen Giarelli (Past-President), Lynette Howington, Erika Maria Monteiro Santos, Diane Seibert and John Twomey. 

    Additional ISONG members contributed with a forward to the book and book reviews: Bernice Coleman, Yvette Conley, Jean Jenkins and Heather Skirton.

    For more information on this book and the complete list of authors please click here.

    • 13 Dec 2017
    • 11:00 AM
    • 13 Dec 2020
    • 11:30 PM
    • webinar Listen On-Demand and earn CE's!
    Register

    The Hope and Hype of Genomic Medicine



    Presented by
    Kevin T. FitzGerald
    SJ, PhD, PhD

    Description
    Almost daily one can find reports in the media touting new and exciting advances in genetic research and genomic medicine. Often implicit in these reports are multiple assumptions about how these advances will benefit our health care and society. The intent of this presentation is to examine some of these new medical technologies and the assumptions often associated with them as to how they will benefit us, to then elucidate fundamental problems inherent in these assumptions, and, finally, to suggest perspectives that could result in a better integration of these genetic and genomic advances into our health care systems and our society.

    Who should Attend?
    Health care providers, educators, researchers, and anyone else interested in learning about the genomic undergirdings of health and associated ethical considerations should attend this webinar. Anyone interested in learning about the ethical considerations of genomic medicine from the a unique perspective of a priest should attend this webinar. 

    Objectives:

    1. To provide an explanation of genetic/genomic medicine as undergirding a new approach to healthcare.
    2. To provide the explication of some of the significant ethical issues raised by genetic/genomic medicine.
    3. To provide possible approaches for addressing the ethical issues raised.

    This webinar is being offered by ISONG at no cost! 

    • 21 Mar 2018
    • 4:00 PM
    • 02 Mar 2020
    • 5:00 PM
    • Webinar
    Register

    ISONG Webinars are now available for institutions!
    This is an opportunity to provide an educational session while providing continuing educational credits in your setting. CE credits are available at $5/each certificate.

    The International Society of Nurses in Genetics (ISONG) is a global specialty nursing organization dedicated to genomic healthcare, education, research, and scholarship. ISONG is known globally for providing high quality educational symposia, presentations, and webinars that provide expert information for nurses using and integrating genomics into their practice, education and research.   

    Webinars provided by ISONG offer valuable genomics-related content, delivered with credibility and authority to nurses interested in gaining low-cost, dedicated access to experts for an hour. ISONG takes careful preparation of matching the expertise of its webinar presenters with the needs of a global nursing audience, with applications to many varied diseased states.  We also place importance on the delivering vital education using text, verbal, and human interaction to optimize learning and allowing for the ability to emphasize key points, theory, and facts to the learner.

    Promoting the continuing education of nurses, ISONG webinars offer continuing nursing education credits. The credits are offered at an optimal price point for the quality and level of learning received and viewing the webinars are at your convenience! 

    Click here to view all ISONG webinars and descriptions. 

    • 17 Apr 2018
    • 16 Apr 2021
    • Webinar
    Register

    What Do We Know About Genomics and Alzheimer’s Disease?


    Presented by
    Julie Eggert
    PhD, GNP-BC, AGN-BC, AOCN, FAAN

    Description
    Providers and researchers will learn more about state of the science in Research and Guidelines. Current research focusing on the genomics of this disease will be described and discussed.

    Who Should Attend?
    Health care providers, educators, researchers, clinical staff working in geriatrics, students, family members of patients with Alzheimer's Disease, and anyone else interested in learning about the relationship between Alzheimer's and genomics. 

    New registration costs for this webinar(rates include ce credits):
    $10.00 for ISONG Members
    $15.00 for Non-Members

    Objectives - After this presentation attendees will know/learn:

    • Review and update the pathophysiology of Alzheimer’s Disease (AD)
    • Describe the genetic mutations/changes (including epigenetics, mitochondrial DNA and telomeres) associated with early onset and late onset AD.
    • Explain known AD therapies and clinical trials for the treatment of this disorder.
    • Discuss the role of the International Genomics Alzheimer’s Project (IGAP) in research.

    Presenter
    Julie Eggert PhD, GNP-BC, AGN-BC, AOCN, FAAN
    Professor Emerita
    Former PhD Program Coordinator, Healthcare Genetics
    School of Nursing/College of Behavioral Social and Health Sciences
    Clemson University 
    Clemson, South Carolina USA

    Dr. Eggert has worked with the elderly most of her professional life.  She taught a Geriatric Nursing course to masters students working on their nursing practice degrees as an FNP and also an Advances in Geriatrics course for GNP students.  In her geriatric faculty role she implemented Geriatric Oncology seminars for providers.  Most recently she wrote a chapter in the Beery, Workman and Eggert - Genetics and Genomics in Nursing and Health Care, 2nd edition entitled “Common Adult-Onset Genetic Disorders which included Alzheimer’s Disease”.  She recently retired as the Coordinator of the Healthcare Genetics PhD program in the School of Nursing at Clemson University in SC, USA and is now functions as a Professor Emerita. 

    Contact Hours
    ISONG and ANA-NY are collaborating to provide this learning activity.  Nurse participants completing the activity and the evaluation tool will receive one (1) continuing nursing education contact hour.  The Northeast Multi-State Division is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

    • 10 Jul 2018
    • 10:00 AM
    • 10 Jul 2022
    • 11:00 AM
    • Webinar
    Register

    Identifying and Treating Monogenic Diabetes


    Presented by
    Maggie Shepherd
    RGN, PhD

    Description
    This webinar will provide an update on monogenic diabetes, highlighting how to identify possible cases and the impact of a genetic diagnosis. Genes causing both maturity onset diabetes of the young (MODY) and neonatal diabetes will be discussed. Simple and inexpensive steps which can be taken to aid differential diagnosis will be described. Case studies will be used to highlight the specific characteristics associated with different types of monogenic diabetes, ensuring the appropriate tests are recommended, enabling accurate diagnosis and most appropriate treatment. Ensuing treatment changes, implications for other family members and the emotional impact of a ‘new genetic diagnosis’ and the consequence of stopping insulin injections, even after many years on this treatment, will be discussed.

    Who Should Attend?
    This webinar will be of interest to all healthcare professionals involved in diabetes care. No previous experience of monogenic diabetes will be required. Any healthcare professionals looking to ensure their patients have the correct diagnosis and treatment and interested in increasing their awareness of monogenic diabetes should attend.

    Objectives
    During this presentation attendees will learn:

    • How to identify individuals likely to have monogenic diabetes
    • Aids to differential diagnosis (for example use of MODY probability calculator, c-peptide and antibodies)
    • Where to access more information on monogenic diabetes

    Presenter
    Maggie Shepherd, RGN, PhD
    Honorary Clinical Professor
    University of Exeter Medical School
    Medical Research
    Exeter, United Kingdom 

    Maggie trained as an RGN at King’s College Hospital and worked as Diabetes Specialist Nurse in Greenwich prior to joining the monogenic diabetes team in Exeter in 1995.  She has a PhD in Medical Science and qualifications in Medical Education, Genetic Counselling and Genomic Medicine. Also, she is the Honorary Clinical Professor at the University of Exeter Medical School, Lead Nurse for Research at the Royal Devon and Exeter NHS Foundation Trust and lead co-ordinator of the national, award winning Genetic Diabetes Nurse project.

    Particular interests include increasing awareness of monogenic diabetes, ensuring correct diagnosis and treatment.  Maggie has over 100 publications (30 first author) and is an Editorial Board member of the European Diabetes Nursing Journal.

    Maggie delivered the Janet Kinson award lecture at DUK in 2003, is a member of the team receiving the Queens Anniversary Prize for Higher and Further Education in 2006, Hospital Doctor Academic Medicine Team of the Year 2005 and BMJ diabetes team of the year 2016. 

    Cost
    $10.00 for ISONG Members
    $15.00 for Non-Members

    Contact Hours

    ISONG and ANA-NY are collaborating to provide this learning activity. Nurse participants completing the activity and the evaluation tool will receive one (1) continuing nursing education contact hour. The Northeast Multi-State Division is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

    • 26 Oct 2018
    • 7:00 AM (EDT)
    • 28 Oct 2018
    • 12:00 PM (EDT)
    • DoubleTree by Hilton Orlando at SeaWorld, Orlando, Florida
    Register


    Please Join Us!

    On behalf of the 2018 ISONG Congress Planning Committee we invite you to join us at the 2018 Congress; "Building Connections to Genomic Health".  The DoubleTree Hotel by Hilton Orlando at Sea World is an outstanding setting to connect with genetics and nursing colleagues from the United States and around the world.

    The theme of the congress is connections in genomic health and we look forward to exciting presentations by keynote speakers, abstract and poster presentations.

    And new for this year, we will have three expert symposia on evolving topics in genetic nursing research and clinical care. The presentations have been chosen to meet the following objectives to:

    • Foster community engagement for genomic health initiatives and encourage bi-directional spread of education, practice and research.
       
    • Identify the use of clinically-relevant online genomics tools for education and research.
       
    • Understand the unique role that human genomic diversity plays in health research and clinical practice.
       
    • Apply the concepts gained through this conference to further integrate new communication methods in their own clinical specialty. 

    We encourage you to join us in Orlando and look forward to greeting you. Please remember the vital support of our Congress sponsors and visit each exhibit to learn about new and valuable contributions to health care and education.  

    Sincerely,

    Deb Tamura, MS, RN  
    Deb Tamura, MS, RN  Michael Groves, PhD, RN, CNE

    Program and information 

    Thank you to our 2018 Sponsors:

       


     

       



         


    Contact Linda Mason at linda@isong.org if you have any questions.


    • 07 Nov 2018
    • 12:00 PM - 1:00 PM
    • Webinar
    Register

    Direct to Consumer Genetic Testing


    Presented by
    Nicole Osier, PhD, RN

    Description
    The purpose of this webinar is to provide the learner with fundamental information regarding the rapidly growing field of direct to consumer testing. The goal is to provide learners with a strong foundation as well as resources to find additional reputable information. Topics for discussion include: (1) what direct to consumer genetic testing is and why it has become so popular; (2) applications of direct to consumer testing and the type of information they can provide; (3) how the testing works; (4) the strengths and limitations of direct-to-consumer testing; (5) factors that can impact results; (6) implications of direct-to-consumer testing on health care. Case studies from several clinical settings will be provided.

    Who Should Attend?
    Clinicians who have patients who have or may come to them with direct to consumer genetic testing results

    • Anyone who has pursued or is considering direct to consumer genetic testing
    • Anyone who is interested in genetic testing for ancestry


    Objectives
     - After this presentation attendees will know/learn:

    • Interpret direct to consumer genetic testing results in light of relevant personal and
       lifestyle characteristics.
    • Understand the strengths and limitations of direct to consumer ancestry tests.
    • Evaluate the real or potential ethical, legal, social, and financial implications of direct to consumer testing.

    Presenter
    Dr. Osier is an Assistant Professor and new addition to the University of Texas at Austin faculty. She holds joint appointments in the School of Nursing (Division of Holistic Adult Health) and Dell Medical School (Department of Neurology). Dr. Osier also serves as the Director of the Biobehavioral Core of St. David’s Center for Health Promotion and Disease Prevention Research in Underserved Populations (CHPR). Dr. Osier’s training background includes dual bachelor’s degrees from Michigan State University (in Nutritional Science and Nursing), a PhD from the University of Pittsburgh (in Nursing with an emphasis on Molecular Genomics), and a post-doctoral fellowship at the National Institutes of Health (in Nursing with an emphasis on Protein Quantification).

    To-date, Dr. Osier’s program of research has centered on using both pre-clinical and clinical research to promote understanding the molecular and genomic underpinnings of health, disease, and injury recovery. Her current research focuses on understanding the pathology associated with traumatic brain injury (TBI). Her ultimate goal is to harness this information to predict individuals at highest risk for poor outcomes and ultimately to inform precision care initiatives. Dr. Osier teaches Genetics in Health Care to undergraduate students, where she strives to incorporate innovative experiential learning methods.

    CE Credits
    ISONG and ANA-NY are collaborating to provide this learning activity.  Nurse participants completing the activity and the evaluation tool will receive one (1) continuing nursing education contact hour.  The Northeast Multi-State Division is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

    Cost: 
    $10.00 for ISONG Members
    $15.00 for Non-Members

    Thank you to our sponsor: 


    23andMe resources for clinicians:

    ·  23andMe’s website for clinicians: view sample genetic reports, webinars and FAQs

    · 23andMe’s Ancestry Composition report

    For questions, contact medical@23andMe.com


© International Society  ofNurses in Genetics (ISONG)
ISONG Privacy Policy
Powered by Wild Apricot Membership Software